Micronutrient inadequacy is the gap between how much of a vitamin or mineral you take in and how much your body would comfortably use, sitting above outright deficiency but below a healthy margin. Bruce Ames's triage theory proposes that when a nutrient runs short, the body spends it on the jobs needed for survival right now and skimps on the slow maintenance that protects you decades later, so a modest lifelong shortfall could raise the risk of cancer, heart disease and faster aging without ever showing up as a diagnosed deficiency. Dietary surveys back the first half: a large share of adults take in less magnesium, vitamin D, vitamin E, calcium and vitamin K than the estimated average requirement.
The theory itself is a hypothesis with real mechanistic support, and it has not been shown that correcting a shortfall lengthens a human life; broad multivitamin use has not clearly cut death or heart disease in randomized trials. The grounded reading: fix the nutrients you are actually short on, from food first, and skip the megadoses.
Findings & Outcomes
Most nutrition attention goes to the two ends of the scale: outright deficiency, the scurvy-and-rickets territory a doctor can diagnose, and megadosing, the shelf of high-strength bottles. The middle is where most people actually live, taking in a little less of several nutrients than the body would ideally use, year after year, with no symptom to point at. This page is about that middle ground and the theory that tries to explain why it might matter.
What Inadequacy Means
Inadequacy is not deficiency. A deficiency is a shortfall large enough to cause a recognized clinical problem: too little vitamin C and gums bleed, too little vitamin D in a child and bones soften. Inadequacy is milder and quieter, an intake below the amount set as sufficient for the population, with nothing you would notice day to day.
The yardstick nutrition scientists use is the estimated average requirement, or EAR: the daily intake judged to meet the needs of half the healthy people in an age and sex group. Counting how many people fall below the EAR is the standard way to size a shortfall across a population. It is a measure of intake against a benchmark, not a blood test, and that distinction runs through everything below.
The Triage Theory
In 2006 the biochemist Bruce Ames proposed a way the quiet middle could still do harm over a lifetime. His triage theory starts from evolution: episodic shortages of vitamins and minerals were common for most of human history, so natural selection would have favored a body that spends a scarce nutrient wisely. Wisely, in survival terms, means on the functions you need to reach reproductive age, not the ones that protect you in old age you might never see.
The proposal is that when a micronutrient runs short, the body allocates it by triage. Proteins and enzymes that depend on that nutrient for immediate survival keep their supply. The ones that depend on it for slow, long-term maintenance, repairing DNA, clearing damaged mitochondria, keeping arteries and bone in good order, lose theirs first. Each shortfall does a little insidious damage that never registers as a deficiency, and the bill arrives decades later as a higher risk of cancer, heart disease and the diseases of aging.
In a 2018 follow-up, Ames extended the idea, sorting nutrient-dependent proteins into survival proteins and what he called longevity proteins, and naming a set of compounds as candidate "longevity vitamins" that the body would ration the same way. It is a framework for thinking about long-term nutrient economy, built from mechanism and evolutionary reasoning, and it has not been tested as a chain of cause and effect in people.
The Evidence For Triage
The theory would be pure speculation if the rationing could not be shown anywhere. Two worked examples give it its footing, both from reviews by Joyce McCann and Ames.
Vitamin K is the clearer case. It is a cofactor for a family of proteins that need a chemical step called carboxylation to work, the Gla proteins. Clotting factors are Gla proteins, and clotting is a survival function: bleed out and you do not reproduce. Other Gla proteins do slow maintenance work, such as matrix Gla protein, which helps keep calcium out of artery walls, and osteocalcin in bone. Reviewing the evidence, McCann and Ames argued that when vitamin K is modestly short, the clotting proteins get carboxylated first and the maintenance proteins go undercarboxylated, which lines up with the observation that inadequate vitamin K tracks with arterial and kidney calcification and bone fragility. That is the triage pattern made concrete: survival function protected, long-term function starved.
Selenium gave a second test. There are 25 human selenoproteins, and if triage is real they should not all fail together when selenium runs low. McCann and Ames classified them and found a hierarchy: about five selenoproteins tied to short-term survival held their function on low selenium, while the seven or so tied to long-term protection lost theirs first, and the same set of aging diseases that track with modest selenium shortfall also track with genetic faults in those "non-essential" selenoproteins. The ranking is inferred from cell and animal work and from disease associations, not proven in a human trial, but it is the kind of prediction the theory has to make, and it held.
How Common Shortfalls Are
The first half of the theory, that modest shortfalls are widespread, is the part with the firmest data. Using US national intake data (NHANES), researchers compared what people actually eat against the EAR for 19 micronutrients. A handful of nutrients were rarely short: fewer than 8% fell below the EAR for folate, zinc, the B vitamins, iron and selenium once fortified foods were counted.
Several others were short in a large share of the population. From food and supplements combined, the fraction below the estimated average requirement was 70% for vitamin D, 60% for vitamin E, 45% for magnesium, 38% for calcium, 34% for vitamin A and 25% for vitamin C. Only about a third of people reached the adequate-intake mark for vitamin K, and potassium was reached by almost nobody. Choline, not in that particular count, falls short for most adults in other national analyses.
These are intakes measured against a benchmark, from diet recalls that people are known to report imperfectly, so the exact percentages carry error and a low intake is not the same as a deficiency in the blood. What the numbers do show is that the shortfalls the triage theory worries about are common rather than rare, and that they cluster in nutrients you can get from ordinary food.
Does A Multivitamin Fix It
Here is where the popular version overruns the science. From "many people are short on several nutrients," it is a short leap to "so everyone should take a multivitamin," and that leap has been tested directly in large randomized trials, which is a stronger design than the intake surveys above.
The evidence for broad supplementation in healthy, well-fed adults is thin. A systematic review for the US Preventive Services Task Force pooled dozens of trials and concluded that the evidence is insufficient to say multivitamins prevent cardiovascular disease or cancer, and it recommended against beta-carotene and vitamin E for that purpose outright. A large cohort that followed 390,124 US adults for up to two decades found no lower mortality among daily multivitamin users, if anything a slightly higher rate early on, which is the fingerprint of people starting supplements when their health is already failing.
A daily multivitamin has not been shown to help a healthy, well-nourished adult live longer or avoid heart disease. Its case is strongest for filling a shortfall you actually have, not as an insurance policy for everyone.
The signals that do exist are modest. In the Physicians' Health Study II, a trial in 14,641 male doctors, a daily multivitamin lowered total cancer by about 8% over roughly 11 years, though small in absolute terms and with no effect on cancer deaths, and the same trial found no reduction in cardiovascular events. In a separate three-year trial, older adults taking a multivitamin scored a little better on cognitive tests than those on placebo, a result that some companion analyses have not reproduced and that is still argued over. None of this is the sweeping benefit the marketing implies, and this page gives no dosing.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Measurement And Diagnosis
70% below the EAR for vitamin D, 60% for vitamin E, 45% for magnesium in US intake data
In a national US survey, most adults took in less vitamin D and vitamin E than the average requirement, and nearly half fell short on magnesium.
Fulgoni and colleagues (J Nutr 2011) applied the National Cancer Institute method to NHANES 2003-2006 (n=16,110, ages 2 and older) to compare usual intakes with the Dietary Reference Intakes. From all sources combined (food, fortification and supplements), the share below the estimated average requirement was 70% for vitamin D, 60% for vitamin E, 45% for magnesium, 38% for calcium, 34% for vitamin A and 25% for vitamin C, while fewer than 8% were short on folate, zinc, iron and the B vitamins. Only about 35% exceeded the adequate intake for vitamin K and almost none for potassium.
The study · 1
Fulgoni 2011, J Nutr · J Nutr
Longevity And Mortality
Evidence insufficient that multivitamins prevent cardiovascular disease or cancer
Pooling many trials, a US expert review found no clear evidence that a daily multivitamin prevents heart disease or cancer in healthy adults.
The US Preventive Services Task Force evidence review (O'Connor 2022, JAMA) searched trials through February 2022 and synthesized 84 studies. It concluded that the evidence is insufficient to assess whether multivitamin supplementation prevents cardiovascular disease or cancer in generally healthy, non-deficient adults, and recommended against beta-carotene and vitamin E for that purpose because trials showed no benefit and beta-carotene raised lung-cancer risk in smokers. The review addresses primary prevention in well-nourished adults, not treatment of a diagnosed deficiency.
The study · 1
No lower mortality among daily multivitamin users across 390,000 US adults
Following nearly 400,000 adults for up to two decades, people who took a daily multivitamin were no less likely to die than people who did not.
Loftfield and colleagues (JAMA Network Open 2024) pooled three prospective US cohorts (390,124 adults, 164,762 deaths, up to 27 years of follow-up). Daily multivitamin use was not associated with lower all-cause mortality; in the earliest follow-up window users had a slightly higher hazard (multivariable hazard ratio near 1.04), consistent with people beginning supplements as their health declines.
The study · 1
Loftfield 2024, JAMA Netw Open · JAMA Netw Open
Nutrient-dependent proteins sorted into survival proteins and long-term longevity proteins
A follow-up idea sorts nutrient-dependent proteins into ones the body needs to survive now and ones that protect long-term health, and says a shortfall sacrifices the second group first.
In a 2018 PNAS perspective Ames extended the triage theory by classifying proteins into survival proteins versus longevity proteins, arguing that a modest deficiency of a nutrient cofactor triggers a rationing mechanism that favors survival proteins while sacrificing longevity proteins, whose impairment insidiously raises the risk of age-related disease. He named candidate longevity vitamins (including ergothioneine, PQQ, queuine and several carotenoids). It is a conceptual classification and review, not an outcome study.
Who this may not transfer to:A conceptual classification and literature review, not a measurement taken in people.
The study · 1
Ames 2018, PNAS · Proc Natl Acad Sci USA
Cancer Risk And Outcome
Daily multivitamin lowered total cancer about 8% in male physicians, with no drop in cancer deaths
In a large trial of male doctors, taking a daily multivitamin for about 11 years modestly lowered the chance of getting cancer, though it did not lower the chance of dying from cancer.
The Physicians' Health Study II (Gaziano 2012, JAMA) randomized 14,641 male US physicians aged 50 and older to a daily multivitamin or placebo, median follow-up 11.2 years. Daily multivitamin use modestly but significantly reduced total cancer (hazard ratio 0.92, an 8% relative reduction) versus placebo. There was no significant effect on cancer mortality or on site-specific cancers such as prostate. The population was well-nourished male physicians, which limits how far the result extends.
Who this may not transfer to:Measured entirely in male US physicians. It has not been tested in women, and a companion women's trial did not exist here, so the effect in women is unknown, neither assumed larger nor smaller.
The study · 1
Gaziano 2012, JAMA (PHS II) · JAMA
Heart And Vascular
Daily multivitamin did not reduce cardiovascular events in male physicians
In the same large trial of male doctors, a daily multivitamin did not lower heart attacks, strokes or cardiovascular death.
The cardiovascular arm of the Physicians' Health Study II (Sesso 2012, JAMA) followed the same 14,641 male physicians for a median 11.2 years. Daily multivitamin use had no effect on major cardiovascular events (hazard ratio 1.01), nor on myocardial infarction, stroke or cardiovascular mortality individually. This was the first long-term randomized trial of a common multivitamin for cardiovascular prevention.
Who this may not transfer to:Measured entirely in male US physicians. The cardiovascular null has not been tested against a women's cohort here, so it is not assumed to transfer either way.
The study · 1
Sesso 2012, JAMA (PHS II) · JAMA
How it works
Triage theory: the body rations a scarce nutrient toward survival, starving long-term repair
The theory says that when a vitamin or mineral runs short, the body protects the jobs it needs to survive right now and skimps on the slow upkeep that guards against disease decades later.
Ames proposed in PNAS (2006) that episodic micronutrient shortages during evolution favored a rationing response: when a nutrient is scarce, functions needed for short-term survival and reproduction are prioritized over functions needed only for long-term health, in part by adjusting the binding affinity of nutrient-dependent proteins. The predicted consequence is insidious accumulation of DNA damage and mitochondrial decay that accelerates cancer, aging and neural decline without producing an overt deficiency. It is presented as a hypothesis supported by mechanistic strands, not a demonstrated cause-and-effect chain in people.
Who this may not transfer to:A mechanistic and evolutionary hypothesis, not a measurement taken in people.
The study · 1
Ames 2006, PNAS · Proc Natl Acad Sci USA
Vitamin K triage: clotting Gla proteins hold their supply while artery and bone Gla proteins lose theirs
When vitamin K is a little short, the clotting proteins that keep you alive get supplied first, and the proteins that keep calcium out of arteries and bone strong get shorted.
McCann and Ames (Am J Clin Nutr 2009) reviewed vitamin K as a worked example of triage. Vitamin K is a cofactor for gamma-carboxylation of Gla proteins; clotting factors (a survival function) are prioritized, while maintenance Gla proteins such as matrix Gla protein (which inhibits arterial calcification) and osteocalcin go undercarboxylated first under modest inadequacy. They linked this pattern to observational associations between low vitamin K status and arterial and kidney calcification, bone fragility and cardiovascular disease.
Who this may not transfer to:A mechanistic review of protein carboxylation hierarchy, not an intervention measured in people.
The study · 1
McCann & Ames 2009, Am J Clin Nutr · Am J Clin Nutr
Selenoprotein hierarchy: survival selenoproteins prioritized over long-term ones under low selenium
The selenium-dependent proteins are not all supplied equally; the ones tied to survival hold up when selenium is low while the ones tied to long-term protection fail first.
McCann and Ames (FASEB J 2011) classified human selenoproteins by essentiality and reported a hierarchy consistent with triage: roughly five selenoproteins tied to short-term survival (for example Gpx4, Txnrd1) retained function under modest selenium deficiency, while about seven tied to long-term protection (for example Gpx1) lost function first. The same age-related conditions (cancer, heart disease, immune dysfunction) prospectively associated with modest selenium shortfall also track with genetic dysfunction of the non-essential selenoproteins.
Who this may not transfer to:A classification of selenoprotein hierarchy from cell, animal and association data, not an intervention measured in people.
The study · 1
McCann & Ames 2011, FASEB J · FASEB J
Cognition
Multivitamin modestly improved cognition over three years in older adults
In a three-year trial, older adults taking a daily multivitamin scored a little better on cognitive tests than those taking a placebo.
COSMOS-Mind (Baker 2023, Alzheimer's & Dementia), a sub-study of the COSMOS trial, randomized older adults to a daily multivitamin-mineral, cocoa extract, both or placebo and assessed cognition by telephone over three years. The multivitamin arm improved global cognition versus placebo, with the authors estimating a benefit roughly equivalent to slowing cognitive aging by about 1.8 years; cocoa extract showed no cognitive effect. Some companion analyses using different cognitive batteries have not reproduced the size of the effect, so it remains debated.
The study · 1
Baker 2023, Alzheimers Dement (COSMOS-Mind) · Alzheimers Dement
The grades below are deliberately uneven. The intake data are graded moderate because the surveys are large and consistent. The triage claims are graded emerging: strong mechanism, no human outcome trial. The multivitamin findings are graded on what the trials showed, a null for death and heart disease sitting beside a modest, real signal for cancer and cognition.
What The Evidence Points To
Two things hold up. Modest shortfalls of a handful of nutrients are common, and the body clearly does prioritize some functions over others when a nutrient is scarce. What has not been shown is that topping up a mild shortfall with pills changes how long or how well a person lives, and broad multivitamin use has not delivered that in trials.
That points to a food-first, target-what-you-lack approach rather than a bottle for everyone:
- The commonly short nutrients come cheaply from food. Magnesium is in nuts, seeds, legumes, whole grains and leafy greens; vitamin K in greens and, as K2, in fermented foods and animal fat; omega-3 in oily fish; choline in eggs and liver; selenium in a couple of Brazil nuts; calcium in dairy, tinned fish with bones and fortified plant milks.
- Vitamin D is the exception food struggles to cover, which is why it tops the shortfall list; sunlight and, in dark months, a modest supplement are the usual routes.
- If you want to know where you actually stand rather than guess, direct-to-consumer lab panels can measure vitamin D, ferritin, magnesium and B12 without waiting on a referral, and a real shortfall is worth correcting.
Go Deeper
The nutrients this page treats as a group each have their own page, graded on their own evidence:
- Vitamin D and magnesium, the two widest shortfalls, and vitamin K2, the triage theory's clearest worked example.
- Omega-3 fish oil for a nutrient most people under-eat, and whole foods, the dietary pattern that covers most shortfalls at once.
- The multivitamin, weighed on its own trial evidence, and the biology of aging, where the long-term-damage side of this theory connects to the wider picture.
Common Questions
What is the difference between inadequacy and deficiency?
Deficiency is a shortfall big enough to cause a clinical problem a doctor can diagnose, like scurvy or rickets. Inadequacy is milder: an intake below the amount judged sufficient for the population, with no symptom you would notice. The triage theory is about inadequacy, the quiet middle, and whether a modest lifelong shortfall does slow damage that never gets labeled a deficiency.
Is the triage theory proven?
No. It is a well-argued hypothesis with real mechanistic support, the vitamin K and selenium examples being the strongest, where survival functions clearly hold their nutrient supply while long-term-maintenance functions lose theirs first. What has not been done is a human trial showing that correcting a modest shortfall changes lifespan or disease. It is a serious idea awaiting that test, not a settled fact.
Should I just take a multivitamin to be safe?
The trials do not support that as a general rule for a healthy, well-fed adult. A systematic review found insufficient evidence that multivitamins prevent heart disease or cancer, and a large cohort found no mortality benefit. There is a modest cancer signal in one big trial and a small cognition signal in another. A multivitamin makes most sense for filling a shortfall you actually have, and food covers most of the commonly short nutrients.
Which nutrients are people most often short on?
By US intake surveys, vitamin D and vitamin E top the list, with most people below the estimated average requirement, followed by magnesium at around 45%, then calcium and vitamin A. Vitamin K and choline are also short for many. These come cheaply from food: greens, nuts, seeds, legumes, oily fish, eggs and dairy cover most of them, which is why the food-first route is the practical one.
The Chinese Medicine Reading
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 10 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 16, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.